Previous close | 43.10 |
Open | 47.25 |
Bid | 47.20 |
Ask | 56.00 |
Strike | 520.00 |
Expiry date | 2026-01-16 |
Day's range | 47.25 - 50.79 |
Contract range | N/A |
Volume | |
Open interest | 776 |
On May 29, 2024, Carmen Bozic, Executive Vice President and Chief Medical Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 2,280 shares of the company.
On May 28, 2024, Charles F. Wagner Jr., Executive Vice President and Chief Financial Officer of Vertex Pharmaceuticals Inc (NASDAQ:VRTX), sold 3,250 shares of the company.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.